Magni P - Search Results

1

Modeling of human tumor xenografts and dose rationale in oncology.

Simeoni M, De Nicolao G, Magni P, Rocchetti M, Poggesi I. Simeoni M, et al. Among authors: magni p. Drug Discov Today Technol. 2013 Sep;10(3):e365-72. doi: 10.1016/j.ddtec.2012.07.004. Drug Discov Today Technol. 2013. PMID: 24050133 Review.

2

Nonparametric AUC estimation in population studies with incomplete sampling: a Bayesian approach.

Magni P, Bellazzi R, De Nicolao G, Poggesi I, Rocchetti M. Magni P, et al. J Pharmacokinet Pharmacodyn. 2002 Dec;29(5-6):445-71. doi: 10.1023/a:1022920403166. J Pharmacokinet Pharmacodyn. 2002. PMID: 12795241

3

In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time.

Germani M, Magni P, De Nicolao G, Poggesi I, Marsiglio A, Ballinari D, Rocchetti M. Germani M, et al. Among authors: magni p. Cancer Chemother Pharmacol. 2003 Dec;52(6):507-13. doi: 10.1007/s00280-003-0688-7. Epub 2003 Aug 16. Cancer Chemother Pharmacol. 2003. PMID: 12923660

4

Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents.

Simeoni M, Magni P, Cammia C, De Nicolao G, Croci V, Pesenti E, Germani M, Poggesi I, Rocchetti M. Simeoni M, et al. Among authors: magni p. Cancer Res. 2004 Feb 1;64(3):1094-101. doi: 10.1158/0008-5472.can-03-2524. Cancer Res. 2004. PMID: 14871843

5

A mathematical model to study the effects of drugs administration on tumor growth dynamics.

Magni P, Simeoni M, Poggesi I, Rocchetti M, De Nicolao G. Magni P, et al. Math Biosci. 2006 Apr;200(2):127-51. doi: 10.1016/j.mbs.2005.12.028. Epub 2006 Mar 3. Math Biosci. 2006. PMID: 16516246

6

A model-based approach to the in vitro evaluation of anticancer activity.

Del Bene F, Germani M, De Nicolao G, Magni P, Re CE, Ballinari D, Rocchetti M. Del Bene F, et al. Among authors: magni p. Cancer Chemother Pharmacol. 2009 Apr;63(5):827-36. doi: 10.1007/s00280-008-0798-3. Epub 2008 Jul 29. Cancer Chemother Pharmacol. 2009. PMID: 18663447

7

A minimal model of tumor growth inhibition.

Magni P, Germani M, De Nicolao G, Bianchini G, Simeoni M, Poggesi I, Rocchetti M. Magni P, et al. IEEE Trans Biomed Eng. 2008 Dec;55(12):2683-90. doi: 10.1109/TBME.2008.913420. IEEE Trans Biomed Eng. 2008. PMID: 19126447

8

Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approach.

Rocchetti M, Del Bene F, Germani M, Fiorentini F, Poggesi I, Pesenti E, Magni P, De Nicolao G. Rocchetti M, et al. Among authors: magni p. Eur J Cancer. 2009 Dec;45(18):3336-46. doi: 10.1016/j.ejca.2009.09.025. Epub 2009 Oct 23. Eur J Cancer. 2009. PMID: 19854637

9

A minimal model of tumor growth inhibition in combination regimens under the hypothesis of no interaction between drugs.

Magni P, Terranova N, Del Bene F, Germani M, De Nicolao G. Magni P, et al. IEEE Trans Biomed Eng. 2012 Aug;59(8):2161-70. doi: 10.1109/TBME.2012.2197680. Epub 2012 May 3. IEEE Trans Biomed Eng. 2012. PMID: 22575633

10

Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts.

Rocchetti M, Germani M, Del Bene F, Poggesi I, Magni P, Pesenti E, De Nicolao G. Rocchetti M, et al. Among authors: magni p. Cancer Chemother Pharmacol. 2013 May;71(5):1147-57. doi: 10.1007/s00280-013-2107-z. Epub 2013 Feb 21. Cancer Chemother Pharmacol. 2013. PMID: 23430120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters